Lenacapavir is a first-in-class HIV capsid inhibitor being investigated for use in HIV-1 treatment. It is a prescription medicine approved by the U.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Lenacapavir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Desmethylsulfonyl Lenacapavir
pharmaceutical intermediate
Lenacapavir
pharmaceutical raw material
Clenbuterol hydrochloride
pharmaceutical raw material
(RS)-hydroxyzine dihydrochloride
pharmaceutical raw material
Ritlecitinib tosylate
pharmaceutical raw material
Baicalin
pharmaceutical raw material
The international HS code for Lenacapavir (CAS 2189684-44-2) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[(1S)-1-[3-[4-chloro-3-(methanesulfonamido)-1-(2,2,2-trifluoroethyl)indazol-7-yl]-6-(3-methyl-3-methylsulfonylbut-1-ynyl)-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-5,5-difluoro-9-(trifluoromethyl)-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide
BRYXUCLEHAUSDY-WEWMWRJBSA-N
CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)NS(=O)(=O)C)[C@H](CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C([C@H]7C[C@H]7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C
Sourcing Lenacapavir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.